Generic Antineoplastic / Chemotherapeutic agent / Anthracyclines

Generic Antineoplastic / Chemotherapeutic agent / Anthracyclines News

Generic Antineoplastic / Chemotherapeutic agent / Anthracyclines Products (13)

  • Product Oncology

    Oncology Tablets, Injections and PFS
  • Product APIs

    • Paclitaxel (Package : Up to 500g Per request) • Pemetrexed (Package : Up to 1kg Per request) • Bortezomib (Package : Up to 40g Per request)
  • Product Fulvestrant

    Indicated for the treatment of Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy, or HR-positive advanced breast cancer in postmenopausal women with disease progression...
  • Product Oncology API# Bulk Sterile # General API

    ONCOLOGY : Cytarabine Gemcitabine Pemetrexate Paclitaxel Letrozole Irrinotecane Bicalutamide Gefitinib Etoposide Anastrazole Dacarbazine Bulk Sterile : Methyle prednisolone Hydrocortisone Pantoprazole Chloramphenicol Colistimethate Polymyxin B Gluthatione General API Suxamethonium Ropivaccaine Neostigmine...
  • Product CDMO

    • Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY  • CYTOTOXIC API • EU GMP  • JGMP (Japan) • KGMP (Korea) • PIC/S
  • Product Erdafitinib

    Indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has susceptible FGFR3 or FGFR2 genetic alterations, and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuva...
  • Product Binimetinib

    Indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation
  • Product Midostaurin

    Indicated, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive, as detected by a FDA approved test
  • Product Ixazomib Citrate

    Indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
  • Product Everolimus

    Indicated for Prophylaxis of Organ Rejection in Kidney Transplantation and Prophylaxis of Organ Rejection in Liver Transplantation
  • Product CDMO injectable oncology

    Cytopharma is a contract development and manufacturing organization (CDMO) that has quickly built a reputation for excellence based on its sterile expertise, innovation and high quality products. Cytopharma has a track record of successful development and launches of more than 20 cytotoxic product. Cytopha...
  • Product INJECTIONS

    Albumin bound Paclitaxel Inj Azacitadine Inj Bendamustin Inj Bortezomib Inj Busulfan Inj Carboplatin Inj Carfilzomib Inj Carmustin Inj Cisplatin Inj Cytrabine Inj Dacarbazine Inj Dactinomycin Inj Degrarelix Inj Doceteaxel Inj Doxorubicin Inj Epirubicin Inj Eribulin Inj Etoposide Inj Fludarabine Inj Fosapre...
  • Product GEMCITABINA 200mg y 1 G


    Fabricado por FARMACO URUGUAYO empresa de la Corporación MEDIFARMA,  Planta de manufactura de productos Oncologicos  en Uruguay, Certificada  por ANVISA de Brasil, CECMED de Cuba, DIGEMID de Perú y MSP de Uruguay, con exportacion a mas de 12 paises de America.


    Manufa...

Upcoming Events

  • CPHI & PMEC India 2024

    India Expo Centre, Greater Noida, Delhi NCR
    26 Nov 2024 - 28 Nov 2024
  • CPHI Middle East 2024

    Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
    10 Dec 2024 - 12 Dec 2024
  • Pharmapack Europe 2025

    Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
    22 Jan 2025 - 23 Jan 2025

Pharmaceutical Industry Webinars